Oppenheimer & Co. Inc. raised its position in Colgate-Palmolive (NYSE:CL – Free Report) by 4.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 38,269 shares of the company’s stock after buying an additional 1,551 shares during the period. Oppenheimer & Co. Inc.’s holdings in Colgate-Palmolive were worth $3,479,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Centricity Wealth Management LLC bought a new position in Colgate-Palmolive in the fourth quarter valued at about $27,000. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $32,000. Bernard Wealth Management Corp. acquired a new stake in shares of Colgate-Palmolive during the 4th quarter worth approximately $36,000. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the third quarter worth approximately $42,000. Finally, Roxbury Financial LLC acquired a new position in Colgate-Palmolive in the fourth quarter valued at approximately $43,000. 80.41% of the stock is owned by institutional investors and hedge funds.
Colgate-Palmolive Stock Performance
CL opened at $91.27 on Friday. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The company has a market capitalization of $74.07 billion, a price-to-earnings ratio of 25.93, a P/E/G ratio of 4.20 and a beta of 0.44. The business’s 50-day moving average price is $88.74 and its two-hundred day moving average price is $95.48. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30.
Colgate-Palmolive Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.19%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 56.82%.
Analysts Set New Price Targets
A number of research firms have commented on CL. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Barclays decreased their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Stifel Nicolaus cut their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research note on Monday, February 3rd. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Finally, Piper Sandler lowered their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $101.61.
Read Our Latest Research Report on CL
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- 3 REITs to Buy and Hold for the Long Term
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Upcoming IPO Stock Lockup Period, Explained
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Investing in Travel Stocks Benefits
- MarketBeat Week in Review – 02/24 – 02/28
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.